Fonaz Suspension 35ml Indications
Fonaz 35ml Suspension is primarily indicated in conditions like Adjunctive therapy without valproate, Candidiasis, Cryptcoccal meningitis, Fungal infection, Neurogenic bladder, Oropharangeal candidiasis, Parkinsonism, Pityriasis versicolor, Vaginal infections, and can also be given in adjunctive therapy as an alternative drug of choice in Bone marrow transplantation, Cryptococcal infections including meningitis, Esophagitis, Urinary tract infection.
Fonaz 35ml Suspension
The severe or irreversible adverse effects of Fonaz 35ml Suspension, which give rise to further complications include Alopecia, Thrombocytopenia, Elevated alkaline phosphatase concentration, Eelvated hepatic enzymes, Hyperlipidemia, Elevated alkaline phosphatase concentration.Fonaz 35ml Suspension produces potentially life-threatening effects which include Severe skin reactions in AIDS, Hepatic necrosis, Death. which are responsible for the discontinuation of Fonaz 35ml Suspension therapy. The signs and symptoms that are produced after the acute overdosage of Fonaz 35ml Suspension include Hallucinations, Paranoid psychosis. The symptomatic adverse reactions produced by Fonaz 35ml Suspension are more or less tolerable and if they become severe, they can be treated symptomatically, these include Dizziness, Headache, Nausea, Vomiting, Diarrhea, Abdominal pain, Rashes, Hypokalemia, Pallor, Anaphylaxis, Leucopenia, dizziness.
Fluconazol should be used with caution in patients with liver disease, kidney disease or of any drug allergy. This medication should be used only when clearly needed during pregnancy. Avoid Fonaz 35ml Suspension during lactation.childern not recommended under one year.Dose adjusted in renal impairment.